Követés
Gad Cotter
Gad Cotter
momentum research
E-mail megerősítve itt: momentum-research.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ...
The Lancet 381 (9860), 29-39, 2013
10142013
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema
G Cotter, E Metzkor, E Kaluski, Z Faigenberg, R Miller, A Simovitz, ...
The Lancet 351 (9100), 389-393, 1998
7551998
Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
BM Massie, CM O'Connor, M Metra, P Ponikowski, JR Teerlink, G Cotter, ...
New England Journal of Medicine 363 (15), 1419-1428, 2010
5892010
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes
M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ...
Journal of the American College of Cardiology 61 (2), 196-206, 2013
5072013
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
JJV McMurray, JR Teerlink, G Cotter, RC Bourge, JGF Cleland, ...
Jama 298 (17), 2009-2019, 2007
3962007
Fluid overload in acute heart failure—re‐distribution and other mechanisms beyond fluid accumulation
G Cotter, M Metra, O Milo‐Cotter, HC Dittrich, M Gheorghiade
European journal of heart failure 10 (2), 165-169, 2008
3562008
The role of the kidney in heart failure
M Metra, G Cotter, M Gheorghiade, L Dei Cas, AA Voors
European heart journal 33 (17), 2135-2142, 2012
3402012
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema
A Sharon, I Shpirer, E Kaluski, Y Moshkovitz, O Milovanov, R Polak, ...
Journal of the American College of Cardiology 36 (3), 832-837, 2000
3102000
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
A Mebazaa, B Davison, O Chioncel, A Cohen-Solal, R Diaz, G Filippatos, ...
The Lancet 400 (10367), 1938-1952, 2022
2982022
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
BA Davison, SA Harrison, G Cotter, N Alkhouri, A Sanyal, C Edwards, ...
Journal of hepatology 73 (6), 1322-1332, 2020
2872020
Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction
E Shemesh, R Yehuda, O Milo, I Dinur, A Rudnick, Z Vered, G Cotter
Psychosomatic medicine 66 (4), 521-526, 2004
2862004
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
G Cotter, E Shemesh, M Zehavi, I Dinur, A Rudnick, O Milo, Z Vered, ...
American heart journal 147 (2), 293-300, 2004
2792004
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
PC Colombo, A Ganda, J Lin, D Onat, A Harxhi, JE Iyasere, N Uriel, ...
Heart failure reviews 17, 177-190, 2012
2342012
The pathophysiology of acute heart failure—is it all about fluid accumulation?
G Cotter, GM Felker, KF Adams, O Milo-Cotter, CM O'Connor
American heart journal 155 (1), 9-18, 2008
2302008
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ...
European heart journal 38 (9), 648-660, 2017
2182017
The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure
G Cotter, Y Moshkovitz, E Kaluski, O Milo, Y Nobikov, A Schneeweiss, ...
European journal of heart failure 5 (4), 443-451, 2003
2152003
Role of cardiac power in heart failure
G Cotter, SG Williams, Z Vered, LB Tan
Current opinion in cardiology 18 (3), 215-222, 2003
2142003
Effects of serelaxin in patients with acute heart failure
M Metra, JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ...
New England Journal of Medicine 381 (8), 716-726, 2019
2092019
Signature of circulating microRNAs in patients with acute heart failure
ES Ovchinnikova, D Schmitter, EL Vegter, JM Ter Maaten, MAE Valente, ...
European journal of heart failure 18 (4), 414-423, 2016
2082016
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure
J Rubio-Gracia, BG Demissei, JM Ter Maaten, JG Cleland, CM O'Connor, ...
International journal of cardiology 258, 185-191, 2018
2012018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20